| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/21/2005 | WO2005035586A1 Fused protein composition |
| 04/21/2005 | WO2005035582A1 Composition of antibody capable of specifically binding ccr4 |
| 04/21/2005 | WO2005035581A1 COMPOSITION OF ANTIBODY CAPABLE OF SPECIFICALLY BINDING HUMAN VEGF RECEPTOR Flt-1 |
| 04/21/2005 | WO2005035579A1 A method for the treatment of maligant diseases by inhibiting nucleolin |
| 04/21/2005 | WO2005035578A1 Antibody composition specifically binding to ganglioside gm2 |
| 04/21/2005 | WO2005035577A1 Antibody composition specifically binding to ganglioside gd3 |
| 04/21/2005 | WO2005035574A1 IgM HIGH CONCENTRATION STABILIZED SOLUTION |
| 04/21/2005 | WO2005035571A1 Novel glycoprotein and medicinal composition containing the same |
| 04/21/2005 | WO2005035561A1 Igf-i responsive gene and use thereof |
| 04/21/2005 | WO2005035548A1 The moduilation of hyaluronan synthesis and degradation in the treatment of disease |
| 04/21/2005 | WO2005035546A1 Peptide nucleic acid conjugates and uses thereof |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035524A1 Pyrrolidinyl urea derivatives as angiogensis inhibitors |
| 04/21/2005 | WO2005035512A1 Thiadiazoline derivatives |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035004A1 COMPOSITION FOR INHIBITING FUNCTION OF HUMAN Flt3 |
| 04/21/2005 | WO2005035003A2 Compositions and methods for increasing drug efficiency |
| 04/21/2005 | WO2005034994A1 Remedy for solid tumor |
| 04/21/2005 | WO2005034984A1 Cd44 splice variant in diagnosis and therapy of intestinal cancer |
| 04/21/2005 | WO2005034963A1 USE OF GINSENOSIDES Rh2 & Rg3, AND AGLYCON GINSENOSIDES FOR THE PREVENTION OF CANCER |
| 04/21/2005 | WO2005034959A1 USE OF 2-METHYLENE-19-NOR-20(S)-1a,25-DIHYDROXYVITAMIN D3 TO INCREASE THE LIFE EXPECTANCY OF HUMAN BEINGS |
| 04/21/2005 | WO2005034953A1 Angiogenesis inhibitor |
| 04/21/2005 | WO2005034950A1 Pyridothiophene compounds |
| 04/21/2005 | WO2005034944A1 Combinations of indole compounds and alkylating agents for the treatment of cancer |
| 04/21/2005 | WO2005034935A1 Use of organoarsenic or organoantimony derivatives for their anticancer properties |
| 04/21/2005 | WO2005034934A1 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir) |
| 04/21/2005 | WO2005016970A3 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 04/21/2005 | WO2005012327A3 Nucleotide phosphoramidates as anticancer agents |
| 04/21/2005 | WO2005010047A3 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof |
| 04/21/2005 | WO2005003776A3 In vitro methods for detecting renal cancer |
| 04/21/2005 | WO2004111019A3 Protective groups cleavable by serumal albumins |
| 04/21/2005 | WO2004108142A3 Inhibitors of tip-1 for treatment tissue damage |
| 04/21/2005 | WO2004105678A3 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions |
| 04/21/2005 | WO2004080398A3 1-amino 1h-imidazoquinolines |
| 04/21/2005 | WO2004069992A3 Oligomeric compounds for the modulation of ras expression |
| 04/21/2005 | WO2004045490A3 Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof |
| 04/21/2005 | WO2004026863A8 Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | WO2002099053A3 Slc22as as modifiers of the p53 pathway and methods of use |
| 04/21/2005 | WO2002092842A3 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
| 04/21/2005 | WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085637 Pyrimidine compounds |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085538 Administering strylacrylonitrile compound; antiproliferative agents; anticancer agents |
| 04/21/2005 | US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/21/2005 | US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents |
| 04/21/2005 | US20050085515 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 04/21/2005 | US20050085513 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085503 used for detecting diseases where N-acetylated alpha -linked acidic dipeptidase (NAALADase) levels are altered, effecting neuronal activity, effecting TGF- beta activity, inhibiting angiogenesis, and treating glutamate abnormalities, cancer, pain |
| 04/21/2005 | US20050085490 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
| 04/21/2005 | US20050085484 Anticancer agents, particluarly mammary glands, rectums; endometriosis; |
| 04/21/2005 | US20050085472 Pyrazolo pyrimidine derivatives and methods of use thereof |
| 04/21/2005 | US20050085471 Using 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-one; enzyme inhibitors; antithrombotic agents ; restenosis; atherosclerosis; antihistamines; chronic obsessive pulminary disease; autoimmune diseases; anticancer agents; antiinflammatory agents |
| 04/21/2005 | US20050085465 Quinazoline compounds |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/21/2005 | US20050085448 Viricides against herpes virus; autoimmune disease; antitumor agents |
| 04/21/2005 | US20050085447 Osteoarthritis; rheumatic disorders ; psoriasis; anklosing spondylitis; atherosclerosis; inflammatory bowel disorders; multiple sclerosis; congestive heart failure; vision defects; chronic obstructive pulmonary disease; asthma; oral diseases; psoriasis; cancer |
| 04/21/2005 | US20050085433 Cellular vaccines comprising adjuvants |
| 04/21/2005 | US20050085416 Stabilized albumin, fatty acid complex; anticancer agents; bactericides |
| 04/21/2005 | US20050084966 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/21/2005 | US20050084936 Human regulatory proteins |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084873 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084486 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/21/2005 | US20050084482 As an antiinflammatory agent for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/21/2005 | CA2578473A1 Peptide nucleic acid conjugates and uses thereof |
| 04/21/2005 | CA2548787A1 Antibody composition specifically binding to ganglioside gm2 |
| 04/21/2005 | CA2546730A1 A method for the treatment of malignant diseases by inhibiting nucleolin |
| 04/21/2005 | CA2542608A1 Igf-i responsive gene and use thereof |
| 04/21/2005 | CA2542099A1 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 04/21/2005 | CA2542046A1 Fused protein composition |
| 04/21/2005 | CA2542037A1 Composition of antibody capable of specifically binding ccr4 |
| 04/21/2005 | CA2542034A1 Thiadiazoline derivatives |
| 04/21/2005 | CA2541438A1 The modulation of hyaluronan synthesis and degradation in the treatment of disease |
| 04/21/2005 | CA2540868A1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors |
| 04/21/2005 | CA2540051A1 Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin d3 to increase the life expectancy of human beings |
| 04/21/2005 | CA2539449A1 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir) |
| 04/21/2005 | CA2537473A1 Cytokine involved in epithelial-mesenchymal transition |
| 04/20/2005 | EP1524273A1 Process for the preparation of trans- or cis-diammoniumdichlorodihydroxyplatinum(IV) salts and derivatives and their use for the preparation of pharmaceutical active agents |
| 04/20/2005 | EP1524262A1 Inhibitors of histone deacetylase |
| 04/20/2005 | EP1523991A1 Anti-cancer vaccine |
| 04/20/2005 | EP1523990A1 Cellular vesicles denoted as 'exosomes', their preparation and use in the stimulation of an immune response |
| 04/20/2005 | EP1523989A1 Anti cancer vaccine derived from autologous plasma or leucocytes |
| 04/20/2005 | EP1523988A1 A composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
| 04/20/2005 | EP1523985A1 Strontium agent and method for treating cancer |
| 04/20/2005 | EP1523984A1 Pharmaceutical composition comprising oxoplatin, salts and derivatives thereof |
| 04/20/2005 | EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/2005 | EP1523577A2 Method for diagnosis of intestinal-type gastric tumors |
| 04/20/2005 | EP1523556A1 Methods of treating conditions associated with an edg-1 receptor |
| 04/20/2005 | EP1523493A1 Novel tubulysin analogues |
| 04/20/2005 | EP1523488A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 04/20/2005 | EP1523485A1 3-furanyl analogs of toxoflavine as kinase inhibitors |
| 04/20/2005 | EP1523484A2 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 04/20/2005 | EP1523481A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 04/20/2005 | EP1523480A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 04/20/2005 | EP1523473A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments |